REV Group, Inc. (REVG) Reports In-Line Q4 EPS ; Offers Guidance

REV Group, Inc. (NYSE: REVG) reported Q4 EPS of $0.51, in-line with the analyst estimate of $0.51. Revenue for the quarter came in at $597.9 million versus the consensus estimate of $630.99 million.

GUIDANCE:

REV Group, Inc. sees FY2025 revenue of $2.3-2.4 billion, versus the consensus of $2.38 billion.

For earnings history and earnings-related data on REV Group, Inc. (REVG) click here.

You May Also Be Interested In

• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c